PTGES2 and skin basal cell carcinoma: In our study, which analyzed 2,408 phenotypes in the FinnGen R10 study (Francis et al., 2022), BCC emerged as the most significant phenotype associated with PTGES2 and RNASET2, affirming their reliability as biomarkers and therapeutic targets for BCC.